Press Release 1999

Press Release 1999

Dr. Muhammed Majeed, president of Sabinsa Corporation, announced that the company has been assigned a patent for CURCUMIN C3 COMPLEX®. The US Patent #5,861,415 dated January 19, 1999, is entitled "Bioprotectant Composition, Method of Use and Extraction Process of Curcuminoids."

Curcuma longa (turmeric root) is one of the most widely used herbs in Ayurveda materia medica. The dried root, which has been used for centuries as a spice, food preservative and a coloring agent, has been found to be a rich source of phenolic compounds, or curcuminoids. Sabinsa’s unique composition (C3 Complex) of the roots’ three main curcuminoids, and their ability to prevent, as well as intervene in free radical activity, has been awarded patent protection and recognition.

Sabinsa Corporation is an application-oriented manufacturing and marketing company which manufactures and supplies quality assured phytonutrients, standardized herbal extracts and specialty tine chemicals used for nutritional, pharmaceutical and food products. Sabinsa distinguishes itself by its extensive research support for its customers and products, and the scientific credentials of its key staff.

 

 

 

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.